Literature DB >> 10923107

Epidemiology of cervical cancer.

A Mohar1, M Frías-Mendívil.   

Abstract

Entities:  

Mesh:

Year:  2000        PMID: 10923107     DOI: 10.3109/07357900009012198

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


× No keyword cloud information.
  17 in total

1.  Genetic analysis of cis regulatory elements within the 5' region of the human papillomavirus type 31 upstream regulatory region during different stages of the viral life cycle.

Authors:  Ellora Sen; Jennifer L Bromberg-White; Craig Meyers
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

2.  Neoadjuvant chemotherapy followed by radical surgery as an alternative treatment to concurrent chemoradiotherapy for young premenopausal patients with FIGO stage IIB squamous cervical carcinoma.

Authors:  ShanShan Yang; Ying Gao; Jing Sun; Bairong Xia; TianBo Liu; HongXia Zhang; Qi Li; Min Xiao; YunYan Zhang
Journal:  Tumour Biol       Date:  2015-01-21

3.  Self-sampling for HPV to enhance uptake of cervical cancer screening: Has the time come in Canada?

Authors:  Aisha Lofters; Mandana Vahabi
Journal:  CMAJ       Date:  2016-04-25       Impact factor: 8.262

4.  Chinese-Australian women's knowledge, facilitators and barriers related to cervical cancer screening: a qualitative study.

Authors:  Cannas Kwok; Kate White; Jessica K Roydhouse
Journal:  J Immigr Minor Health       Date:  2011-12

5.  Screening for cervical cancer in women with disability and multimorbidity: a retrospective cohort study in Ontario, Canada.

Authors:  Aisha Lofters; Sara Guilcher; Richard H Glazier; Susan Jaglal; Jennifer Voth; Ahmed M Bayoumi
Journal:  CMAJ Open       Date:  2014-10-01

6.  Patients treated with neoadjuvant chemotherapy + radical surgery + adjuvant chemotherapy in locally advanced cervical cancer: long-term outcomes, survival and prognostic factors in a single-center 10-year follow-up.

Authors:  Daniela Luvero; Francesco Plotti; Alessia Aloisi; Stella Capriglione; Roberto Ricciardi; Andrea Miranda; Salvatore Lopez; Giuseppe Scaletta; Giovanna De Luca; Pierluigi Benedetti-Panici; Roberto Angioli
Journal:  Med Oncol       Date:  2016-08-30       Impact factor: 3.064

7.  Feasibility and safety of carboplatin plus paclitaxel as neoadjuvant chemotherapy for locally advanced cervical cancer: a pilot study.

Authors:  Roberto Angioli; Francesco Plotti; Daniela Luvero; Alessia Aloisi; Federica Guzzo; Stella Capriglione; Corrado Terranova; Carlo De Cicco Nardone; Pierluigi Benedetti-Panici
Journal:  Tumour Biol       Date:  2014-03

8.  Human papillomavirus type 16 E7 oncoprotein associates with E2F6.

Authors:  Margaret E McLaughlin-Drubin; Kyung-Won Huh; Karl Münger
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

9.  Long-term follow-up of neoadjuvant intraarterial chemotherapy using an original four-lumen double-balloon (4L-DB) catheter for locally advanced uterine cervical cancer.

Authors:  Yoshito Terai; Masanori Kanemura; Hiroshi Sasaki; Satoshi Tsunetoh; Yoshimichi Tanaka; Yoshiki Yamashita; Kazuhiro Yamamoto; Isamu Narabayashi; Masahide Ohmichi
Journal:  Int J Clin Oncol       Date:  2009-02-20       Impact factor: 3.402

10.  Comparative study of neoadjuvant chemotherapy before radical hysterectomy and radical surgery alone in stage IB2-IIA bulky cervical cancer.

Authors:  Yun-Hyun Cho; Dae-Yeon Kim; Jong-Hyeok Kim; Yong-Man Kim; Young-Tak Kim; Joo-Hyun Nam
Journal:  J Gynecol Oncol       Date:  2009-03-31       Impact factor: 4.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.